Scarica l'app Stockscreener
1.85
5.61%
-0.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.96
Aprire:
$1.92
Volume 24 ore:
242.58K
Relative Volume:
1.10
Capitalizzazione di mercato:
$59.14M
Reddito:
$80.97M
Utile/perdita netta:
$-78.31M
Rapporto P/E:
-0.1669
EPS:
-11.0849
Flusso di cassa netto:
$-129.56M
1 W Prestazione:
-7.50%
1M Prestazione:
+6.32%
6M Prestazione:
-4.64%
1 anno Prestazione:
-6.09%
Intervallo 1D:
$1.85
$1.94
Intervallo di 1 settimana:
$1.85
$2.15
Portata 52W:
$1.325
$2.89
Fortress Biotech Inc Stock (FBIO) Company Profile
Nome
Fortress Biotech Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Confronta FBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.85 | 59.14M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-15 | Ripresa | ROTH MKM | Buy |
| 2022-08-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-02 | Iniziato | The Benchmark Company | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2018-02-28 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
| 2017-03-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-10-03 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Fortress Biotech Inc Borsa (FBIO) Ultime notizie
Two Sigma Investments LP Invests $109,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewswire
Jane Street Group LLC Takes Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO - ACCESS Newswire
Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance
Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus
Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz
Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com
Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire
Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga
Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan
Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India
One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st
Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News
New Strong Sell Stocks for May 16th - The Globe and Mail
Q2 EPS Estimates for Fortress Biotech Raised by Roth Capital - Defense World
How the (FBIOP) price action is used to our Advantage - news.stocktradersdaily.com
Sun Pharma Q4 Consol Net PAT 21.5 Billion Rupees - marketscreener.com
Fortress Biotech Reports Q1 2025 Financial Highlights - TipRanks
Fortress Biotech First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, S - GuruFocus
Fortress Biotech: Q1 Earnings Snapshot - CT Insider
Fortress Biotech (FBIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Fortress Biotech, Inc. SEC 10-Q Report - TradingView
Fortress Biotech Inc (FBIO) Reports Q1 2025 Revenue of $13.1M, Surpassing Estimates - GuruFocus
Fortress Biotech Reports First Quarter 2025 Financial Results an - GuruFocus
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Fortress Biotech (FBIO) Projected to Post Quarterly Earnings on Wednesday - Defense World
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire
INDIA STOCKS-Indian benchmarks jump 2.5% as India-Pakistan truce fuels relief rally - marketscreener.com
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference | FBIO Stock News - GuruFocus
Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference - The Manila Times
Renaissance Technologies LLC Has $356,000 Stock Holdings in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Fortress Biotech, Inc. (NASDAQ:FBIO) Stock Position Boosted by Envestnet Asset Management Inc. - Defense World
Geode Capital Management LLC Increases Stock Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - The Globe and Mail
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - ADVFN
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
Fortress Biotech Board Member Resigns for New Role - TipRanks
When the Price of (FBIOP) Talks, People Listen - news.stocktradersdaily.com
Fortress Biotech (NASDAQ:FBIOP) Trading Down 2.1% – What’s Next? - Defense World
This Fortress Biotech Insider Increased Their Holding By 26% Last Year - Yahoo Finance
Roth Capital Forecasts Reduced Earnings for Fortress Biotech - Defense World
Fortress Biotech Inc Azioni (FBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):